Advances In Nanocarrier-Based Drug Delivery Systems For Targeted Cancer Therapy

Rabia Hassan

Department of Mass Communication, Allama Iqbal Open University

Keywords: Nanocarriers, Targeted Drug Delivery, Cancer Therapy, Precision Oncology


Abstract

Nanocarrier-based drug delivery systems have revolutionized targeted cancer therapy by improving drug solubility, stability, and bioavailability while minimizing systemic toxicity. These systems, including liposomes, polymeric nanoparticles, dendrimers, and inorganic nanoparticles, enable precise delivery of chemotherapeutics to tumor cells through passive and active targeting mechanisms. Recent advances in nanotechnology and surface functionalization have enhanced tumor-specific accumulation, controlled release, and immunomodulatory effects. This article reviews the latest developments in nanocarrier platforms, evaluates their clinical potential, and explores challenges in translation, regulatory compliance, and large-scale manufacturing. The study emphasizes how nanocarrier-based strategies can advance precision oncology and improve therapeutic outcomes.